tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY

Oncolytics Biotech (ONCY) Financial Statements

1,045 Followers

Oncolytics Biotech Financial Overview

Oncolytics Biotech's market cap is currently ―. The company's EPS TTM is $-0.307; its P/E ratio is -3.25; Oncolytics Biotech is scheduled to report earnings on May 3, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -3.91MC$ -9.92MC$ -7.39MC$ -6.44M-
EBITDAC$ -3.80MC$ -9.81MC$ -7.30MC$ -6.34M-
Net Income Common StockholdersC$ -3.95MC$ -9.93MC$ -7.44MC$ -6.44MC$ -8.55M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 34.91MC$ 39.98MC$ 24.35MC$ 29.67MC$ 32.14M
Total AssetsC$ 38.82MC$ 46.09MC$ 31.97MC$ 35.33MC$ 37.33M
Total DebtC$ 423.00KC$ 514.00KC$ 479.00KC$ 567.00KC$ 373.00K
Net DebtC$ -34.49MC$ -39.47MC$ -23.87MC$ -29.10MC$ -31.77M
Total LiabilitiesC$ 11.26MC$ 17.07MC$ 9.73MC$ 9.58MC$ 10.83M
Stockholders EquityC$ 27.56MC$ 29.02MC$ 22.24MC$ 25.75MC$ 26.50M
Cash Flow-
Free Cash FlowC$ -6.13MC$ -6.03MC$ -8.46MC$ -7.83M-
Operating Cash FlowC$ -6.12MC$ -6.03MC$ -8.46MC$ -7.83MC$ -5.94M
Investing Cash FlowC$ -3.00KC$ 6.77MC$ 6.79MC$ 6.67MC$ -20.35M
Financing Cash FlowC$ 1.74MC$ 21.29MC$ 3.69MC$ 5.27MC$ 5.87M
Currency in CAD

Oncolytics Biotech Earnings and Revenue History

Oncolytics Biotech Debt to Assets

Oncolytics Biotech Cash Flow

Oncolytics Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis